Optimi Health Secures Amendment to Increase Quantities Of MDMA, MDA, And 2C-B Under Controlled Drugs And Substances Dealer’s Licence
19 janv. 2024 07h30 HE
|
Optimi Health Corp.
Optimi Health granted amendment to its Health Canada Controlled Drugs and Substances Licence.
MAPS Unveils Improved Fiscal Sponsorship Program, Empowering Innovators in the Psychedelic Movement
16 janv. 2024 16h27 HE
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
To date, MAPS has supported nearly 70 organizations worldwide to advance charitable projects in the psychedelic movementCurrently, MAPS serves as a fiscal sponsor for 10 organizations in the newly...
PharmAla-1 Molecule Receives US Patent Prosecution Highway Acceptance
08 janv. 2024 08h55 HE
|
PharmAla Biotech
PharmAla announces that its novel P1 molecule has been accepted by USPTO to its accelerated "Patent Prosecution Highway"
Optimi Health Granted Precursor Licence To Formulate MDMA And Completes Encapsulation Of 40mg And 60mg Dosage Formats
03 janv. 2024 07h30 HE
|
Optimi Health Corp.
Optimi Health Granted Precursor Licence for 3,4-Methylenedioxyphenyl-2-propanone (“MDP2P”), the precursor used in the chemical synthesis of MDMA.
PharmAla Files Audited Financials for Year Ending August 31, 2023
29 déc. 2023 16h00 HE
|
PharmAla Biotech
PharmAla releases audited year-end financials for the period ended August 31st.
Sunstone Therapies Announces Publication of Positive Phase 2 Study Results in Cancer
18 déc. 2023 07h00 HE
|
Sunstone Therapies
Sunstone Therapies Announces Publication of Positive Phase 2 Study Results in Cancer Phase 2 trial demonstrated the safety and efficacy of psilocybin-assisted group therapy for...
Beckley Academy Welcomes New Faculty for 2024 Psychedelic Therapy Practitioners Courses
14 déc. 2023 09h00 HE
|
Beckley Academy
Beckley Academy Welcomes New Faculty for 2024 Psychedelic Therapy Practitioners Courses
Sunstone Therapies Celebrates Three Year Anniversary With More Than 100 Psychedelic-Assisted Therapy Treatments Completed
14 déc. 2023 07h00 HE
|
Sunstone Therapies
Sunstone Therapies Celebrates Three Year Anniversary With More Than 100 Psychedelic-Assisted Therapy Treatments Completed Sunstone has developed an unrivalled expertise and experience in...
Beckley Retreats Announces Expanded Scholarship Program, Alongside New Specialty Programs for Underserved Communities
11 déc. 2023 11h27 HE
|
Beckley Retreats
Beckley Retreats Announces Expanded Scholarship Program, Alongside New Specialty Programs for Underserved Communities
Optimi Health and Sunshine Earth Labs Ltd. Forge Strategic Supply Agreement
07 déc. 2023 07h30 HE
|
Optimi Health Corp.
Optimi Health and Sunshine Earth Labs Ltd. Forge Strategic Supply Agreement